INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 47.53 million by 2029 | 7.40 % | North America |
| by Type | By Technology | by End User | By Region |
|---|---|---|---|
|
|
|
|
SCOPE OF THE REPORT
Lymphedema Diagnostics Market Overview
The lymphedema diagnostics market is expected to grow at 7.40 % CAGR from 2022 to 2029. It is expected to reach above USD 47.53 million by 2029 from USD 25 million in 2020.
A chronic illness known as lymphedema causes tissues to bulge as extra fluid builds up inside of them. Lymphatic blockage, which typically affects the arms and legs, is another name for lymphedema. Some people even endure chest, head, and vaginal swelling.
Additionally, it is anticipated that enhanced diagnostic solutions offered by technological improvements will fuel market revenue growth. For instance, tracking and treating lymphedema in the future will be made possible using Bio impedance Spectroscopy (BIS), which is scalable and simple to incorporate into workflows. Doctors and therapists may spend more time on patients due to BIS, which can be administered by licensed clinical staff and does away with the need for an examining room. Finally, BIS supports early detection to enable therapy that can significantly increase the likelihood of preventing cancer-related lymphedema for at-risk persons.
It is believed that as people become older, chronic limb edoema will become more common. Over 5.4 out of 1,000 patients over the age of 65 are known to be affected by the prevalence, which is thought to be 1.3 per 100,000 people in the community. A severe issue affecting one in every five breast cancer patients, chronic arm edoema is also thought to occur in 22% of cases of breast cancer survivors every year. The market for lymphedema diagnostics is expanding as a result of the increased prevalence of cancer-associated lymphedema and the desire for its diagnosis.
Major challenges that may impede the growth of the market’s revenue include high costs for diagnostic equipment and inadequate reimbursements. For instance, women pay significant out-of-pocket costs for breast cancer and lymphedema. The high expense of the tools and the high degree of technical competence required to utilize them and interpret the results remain the main downsides of magnetic resonance imaging (MRI). The lack of adequate, clinically approved lymphatic-specific MRI tracers has also hindered the usefulness of this imaging technique, which may be a factor in the potential slow expansion of the industry.
The development of non-invasive and portable diagnostic instruments, the rising use of cutting-edge imaging technologies, and the market’s expansion into developing nations are just a few of the growth prospects presented by the lymphedema diagnostics market. The desire for focused therapies and personalized medicine is also rising, which offers a chance for the creation of diagnostic instruments that are more precise and effective. Additionally, partnerships between major market companies and research institutes are anticipated to spur innovation and broaden the industry.
On the market for lymphedema diagnoses, the COVID-19 epidemic has had a conflicting effect. One the one hand, the pandemic has reduced the need for elective operations, such as lymphedema diagnostics, which has hurt the industry. However, the epidemic has made it clear how crucial it is to get a diagnosis as soon as possible, which is what will likely increase demand for lymphedema diagnoses in the years to come. In addition, it is anticipated that the development of portable and non-invasive diagnostic instruments would expand their usage in telemedicine and remote monitoring applications both during and after the pandemic.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Million). |
| Segmentation | By Type, By Technology, By Disease Type, End User, By Region. |
| By Type
 |
|
| By Technology
 |
|
| By Disease Type
 |
|
| By End User |
|
| By Region
 |
|
Lymphedema Diagnostics Market Segment Analysis
The lymphedema diagnostics market is segmented based on type, technology, disease type and end user.
It primarily results from gene defects that interfere with the lymphatic system’s development. Compared to secondary lymphedema, this form has a lower incidence. Damage to the lymphatic system leads to secondary lymphedema. Injury, infection, and cancer treatment are a few of the causes of lymphatic system damage. The type segment’s largest share belongs to this segment. The primary driver of segmental expansion is increasing incidence and prevalence of cases.
The market for lymphedema diagnostics has been divided into categories based on technology, including lymphoscintigraphy, computed tomography, ultrasound imaging, magnetic resonance imaging, and others. During the forecast period, it is anticipated that the lymphoscintigraphy segment will contribute the biggest revenue share. This is due to the potential for early disease identification and the ability of lymphoscintigraphy to identify molecular activity.
The market for lymphedema diagnostics has been divided into categories for cancer, cardiovascular disease (CVD), inflammatory disorders, and other diseases based on the kind of illness. During the projected period, it is anticipated that the cancer section will provide a sizably substantial portion of the total revenue. This is brought on by the rising incidence of cancer-related lymphedema.
Hospitals, diagnostic centers, and other entities make up the different end use segments of the lymphedema diagnostics market. During the projected period, the hospitals segment is anticipated to account for a sizably big revenue share. This is due to an increase in the number of people who seek out hospitals to do diagnostic procedures. By using specialized massage techniques and their understanding of the most recent treatment options, skilled physical therapists and lymphedema therapists can also assist patients in regaining balance and taking control of their lives.
Lymphedema Diagnostics Market Player
The lymphedema diagnostics market key players includes General Electric Company, Siemens AG, Koninklijke Philips N.V., Canon, Inc., Stryker Corporation, Hitachi, Ltd., Neusoft Corporation, Esaote SPA, Shimadzu Corporation, Mindray Medical International Limited.
Recent News:
16 February 2023: Siemens announced the launch of private industrial 5G user equipment, a critical component for the manufacturing industry in its digital transformation journey.
17 August 2021: Siemens Limited and Tata Power Delhi Distribution Limited (Tata Power-DDL) jointly announced the successful deployment of Smart Metering Technology for over 2,00,000 Smart Meters in North Delhi.
Lymphedema Diagnostics Market Regional Analysis
The lymphedema diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
During the projected period, North America is anticipated to generate the greatest revenue share due to rising cancer-related lymphedema incidence. For instance, each year more than 1 million Americans suffer from lymphedema, a potentially serious illness. Other variables influencing revenue growth in this region include the expanding usage of technologically advanced diagnostic imaging technology and better insurance coverage policies.
Over the projection period, the Europe market is anticipated to see the quickest revenue growth. This is a result of increased funding and research and development (R&D) efforts to create novel technologies that enable early disease identification. As an illustration, the Lymphit project, which is supported by the European Union (EU), has developed a state-of-the-art microneedle-based technology for analysing the lymphatic system using a fluorescent dye to improve lymphedema detection at an early stage. Due to quantitative dye monitoring, which provides knowledge regarding the health of the lymphatic system, therapy may be initiated when the issue is treatable.
Key Market Segments: Lymphedema Diagnostics Market
Lymphedema Diagnostics Market By Type, 2020-2029, (USD Million).
- Primary
- Secondary
Lymphedema Diagnostics Market By Technology, 2020-2029, (USD Million).
- Lymphoscintigraphy
- Magnetic Resonance Imaging
- Computed Tomography
- Ultrasound Imaging
- Others
Lymphedema Diagnostics Market By Disease Type, 2020-2029, (USD Million).
- Cancer
- Inflammatory Disease
- Cardiovascular Disease
- Others
Lymphedema Diagnostics Market By End User, 2020-2029, (USD Million).
- Hospitals
- Diagnostic Centers
- Others
Lymphedema Diagnostics Market By Region, 2020-2029, (USD Million).
- North America
- Asia Pacific
- Europe
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Who Should Buy? Or Key Stakeholders
- Diagnostic tool manufacturers
- Healthcare providers
- Research institutions
- Regulatory authorities
- Patient advocacy groups
- Health insurance companies
- Distributors and suppliers
- Others
Key Question Answered
- What is the expected growth rate of the lymphedema diagnostics market over the next 7 years?
- Who are the major players in the lymphedema diagnostics market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such As Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the lymphedema diagnostics market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the lymphedema diagnostics market?
- What is the current and forecasted size and growth rate of the global lymphedema diagnostics market?
- What are the key drivers of growth in the lymphedema diagnostics market?
- What are the distribution channels and supply chain dynamics in the lymphedema diagnostics market?
- What are the technological advancements and innovations in the lymphedema diagnostics market and their impact on material development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the lymphedema diagnostics market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the lymphedema diagnostics market?
- What are the service offerings and specifications of leading players in the market?
Exactitude Consultancy Services Key Objectives
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA TECHNOLOGYS
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON LYMPHEDEMA DIAGNOSTICS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET OUTLOOK
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLION), 2020-2029
- PRIMARY
- SECONDARY
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLION) , 2020-2029
- LYMPHOSCINTIGRAPHY
- MAGNETIC RESONANCE IMAGING
- COMPUTED TOMOGRAPHY
- ULTRASOUND IMAGING
- OTHERS
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLION) , 2020-2029
- CANCER
- INFLAMMATORY DISEASE
- CARDIOVASCULAR DISEASE
- OTHERS
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLION) , 2020-2029
- HOSPITALS
- DIAGNOSTIC CENTERS
- OTHERS
- GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY REGION (USD MILLION) , 2020-2029
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- GENERAL ELECTRIC COMPANY
- SIEMENS AG
- KONINKLIJKE PHILIPS N.V.
- CANON, INC.
- STRYKER CORPORATION
- HITACHI, LTD.
- NEUSOFT CORPORATION
- ESAOTE SPA
- SHIMADZU CORPORATION
- MINDRAY MEDICAL INTERNATIONAL LIMITED*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 2 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 3 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 4 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 5 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY REGION (USD MILLIONS), 2020-2029
TABLE 6 NORTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 7 NORTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 8 NORTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 9 NORTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 10 NORTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 11 US LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 12 US LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 13 US LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 14 US LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 15 CANADA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (MILLIONS), 2020-2029
TABLE 16 CANADA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 17 CANADA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 18 CANADA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 19 MEXICO LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 20 MEXICO LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 21 MEXICO LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 22 MEXICO LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 23 SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 24 SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 25 SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 26 SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 27 SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 28 BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 29 BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 30 BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 31 BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 32 ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 33 ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 34 ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 35 ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 36 COLOMBIA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 37 COLOMBIA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 38 COLOMBIA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 39 COLOMBIA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 40 REST OF SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 41 REST OF SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 42 REST OF SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 43 REST OF SOUTH AMERICA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 44 ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 45 ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 46 ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 47 ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 48 ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 49 INDIA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 50 INDIA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 51 INDIA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 52 INDIA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 53 CHINA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 54 CHINA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 55 CHINA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 56 CHINA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 57 JAPAN LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 58 JAPAN LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 59 JAPAN LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 60 JAPAN LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 61 SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 62 SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 63 SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 64 SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 65 AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 66 AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 67 AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 68 AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 69 SOUTH EAST ASIA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 70 SOUTH EAST ASIA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 71 SOUTH EAST ASIA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 72 SOUTH EAST ASIA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 73 REST OF ASIA PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 74 REST OF ASIA PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 75 REST OF ASIA PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 76 REST OF ASIA PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 77 EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 78 EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 79 EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 80 EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 81 EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 82 GERMANY LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 83 GERMANY LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 84 GERMANY LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 85 GERMANY LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 86 UK LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 87 UK LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 88 UK LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 89 UK LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 90 FRANCE LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 91 FRANCE LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 92 FRANCE LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 93 FRANCE LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 94 ITALY LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 95 ITALY LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 96 ITALY LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 97 ITALY LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 98 SPAIN LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 99 SPAIN LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 100 SPAIN LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 101 SPAIN LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 102 RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 103 RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 104 RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 105 RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 106 REST OF EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 107 REST OF EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 108 REST OF EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 109 REST OF EUROPE LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 110 MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 111 MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 112 MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 113 MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 114 MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY COUNTRY (USD MILLIONS), 2020-2029
TABLE 115 UAE LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 116 UAE LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 117 UAE LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 118 UAE LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 119 SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 120 SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 121 SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 122 SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 123 SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 124 SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 125 SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 126 SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
TABLE 127 REST OF MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE (USD MILLIONS), 2020-2029
TABLE 128 REST OF MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS), 2020-2029
TABLE 129 REST OF MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE (USD MILLIONS), 2020-2029
TABLE 130 REST OF MIDDLE EAST AND AFRICA LYMPHEDEMA DIAGNOSTICS MARKET BY END USER (USD MILLIONS), 2020-2029
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE, USD MILLION, 2020-2029
FIGURE 9 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY, USD MILLION, 2020-2029
FIGURE 10 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE, USD MILLION, 2020-2029
FIGURE 11 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY END USER, USD MILLION, 2020-2029
FIGURE 12 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 13 PORTER’S FIVE FORCES MODEL
FIGURE 14 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TYPE, USD MILLION, 2021
FIGURE 15 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY TECHNOLOGY, USD MILLION, 2021
FIGURE 16 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY DISEASE TYPE, USD MILLION, 2021
FIGURE 17 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY END USER, USD MILLION, 2021
FIGURE 18 GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET BY REGION 2021
FIGURE 19 MARKET SHARE ANALYSIS
FIGURE 20 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
FIGURE 21 SIEMENS AG: COMPANY SNAPSHOT
FIGURE 22 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 23 CANON, INC.: COMPANY SNAPSHOT
FIGURE 24 STRYKER CORPORATION: COMPANY SNAPSHOT
FIGURE 25 HITACHI, LTD.: COMPANY SNAPSHOT
FIGURE 26 NEUSOFT CORPORATION: COMPANY SNAPSHOT
FIGURE 27 ESAOTE SPA: COMPANY SNAPSHOT
FIGURE 28 SHIMADZU CORPORATION: COMPANY SNAPSHOT
FIGURE 29 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT
FAQ
The lymphedema diagnostics market is expected to grow at 7.40 % CAGR from 2022 to 2029. It is expected to reach above USD 47.53 million by 2029 from USD 25 million in 2020.
North America held more than 40 % of the lymphedema diagnostics market revenue share in 2021 and will witness expansion in the forecast period.
Additionally, it is anticipated that enhanced diagnostic solutions offered by technological improvements will fuel market revenue growth. For instance, tracking and treating lymphedema in the future will be made possible using Bio impedance Spectroscopy (BIS), which is scalable and simple to incorporate into workflows.
During the projected period, it is anticipated that the cancer section will provide a sizably substantial portion of the total revenue. This is brought on by the rising incidence of cancer-related lymphedema.
During the projected period, North America is anticipated to generate the greatest revenue share due to rising cancer-related lymphedema incidence. For instance, each year more than 1 million Americans suffer from lymphedema, a potentially serious illness. Other variables influencing revenue growth in this region include the expanding usage of technologically advanced diagnostic imaging technology and better insurance coverage policies.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.